Pfizer wins appeal of £84M fine over U.K. epilepsy drug price hike by Eric Sagonowsky Friday, June 8, 2018 After U.K. antitrust authorities smacked Pfizer with a record fine over a 2,600% price hike, the drugmaker won an appeal.
Concordia price hikes draw U.K. antitrust probe by Tracy Staton Tuesday, November 21, 2017 U.K. antitrust watchdogs are targeting Concordia and its pricing for liothyonine, a thyroid drug that now costs 57 times more than it did in 2006.
U.K. watchdog smacks Pfizer with record fine, citing a 2,600% price hike by Tracy Staton Wednesday, December 7, 2016 The U.K. government slapped Pfizer with a record price-gouging fine for triggering a 2,600% price increase on an epilepsy drug.
